FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 57 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $33,000 | -92.7% | 10,898 | -94.2% | 0.00% | – |
| Q2 2019 | $450,000 | +800.0% | 189,511 | +1295.4% | 0.00% | – |
| Q1 2019 | $50,000 | +47.1% | 13,581 | +131.1% | 0.00% | – |
| Q3 2018 | $34,000 | -87.8% | 5,877 | -89.5% | 0.00% | – |
| Q2 2018 | $279,000 | +416.7% | 55,903 | +429.1% | 0.00% | – |
| Q1 2018 | $54,000 | +3.8% | 10,565 | +21.4% | 0.00% | – |
| Q4 2017 | $52,000 | -44.7% | 8,706 | -49.2% | 0.00% | – |
| Q3 2017 | $94,000 | -81.3% | 17,142 | -84.2% | 0.00% | – |
| Q2 2017 | $502,000 | +112.7% | 108,222 | +125.9% | 0.00% | – |
| Q1 2017 | $236,000 | +3.1% | 47,898 | +132.1% | 0.00% | – |
| Q4 2016 | $229,000 | -9.1% | 20,637 | -24.3% | 0.00% | – |
| Q3 2016 | $252,000 | -55.7% | 27,269 | -69.6% | 0.00% | – |
| Q2 2016 | $569,000 | +62.1% | 89,665 | +65.8% | 0.00% | – |
| Q1 2016 | $351,000 | -25.3% | 54,079 | -7.0% | 0.00% | – |
| Q4 2015 | $470,000 | -10.3% | 58,169 | -19.0% | 0.00% | – |
| Q3 2015 | $524,000 | -1.5% | 71,806 | +38.1% | 0.00% | – |
| Q2 2015 | $532,000 | +120.7% | 52,009 | +50.8% | 0.00% | – |
| Q4 2014 | $241,000 | +36.2% | 34,499 | +5.8% | 0.00% | – |
| Q3 2014 | $177,000 | – | 32,609 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| NATIONS FINANCIAL GROUP INC, /IA/ /ADV | 20,150 | $0 | 0.00% |
| Advisory Services Network, LLC | 2,233 | $0 | 0.00% |
| Fernwood Investment Management, LLC | 34,000 | $0 | 0.00% |